Sequence analysis for detection of drug resistance in Mycobacterium tuberculosis complex isolates from the Central Region of Cameroon

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Tekwu, Emmanuel Mouafo ^a,e,f   Sidze, Larissa Kamgue ^a,e,f   Assam, Jean Paul Assam ^a,f   Tedom, Jean Claude ^a,f   Tchatchouang, Serges ^a,f   Makafe, Gaëlle Guiewi ^a,f   Wetewale, Anne Laure Tchokote ^a,f   Kuaban, Christopher ^b   Eyangoh, Sara ^c   Ntoumi, Francine ^d,e,f   Beng, Véronique N Penlap ^a,f   Frank, Matthias ^e,f,g  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Jamot Hospital   (Cameroon)

^c CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^d Fondation Congolaise Pour la Recherche Médicale Université Marien Gouabi   (Congo)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f Central African Network for Tuberculosis AIDS HIV and Malaria (CANTAM)   (Congo)

^g Deutsches Zentrum für Infektionsforschung DZIF   (Germany)

Author keywords

Cameroon; Drug resistance; Mutation; Mycobacterium tuberculosis; Phenotype

Indexed keywords

DNA; ETHAMBUTOL; ISONIAZID; MOLECULAR MARKER; STREPTOMYCIN;

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CAMEROON; CODON; CONTROLLED STUDY; DNA SEQUENCE; DRUG RESISTANT TUBERCULOSIS; GENE MUTATION; GENETIC SCREENING; INHA GENE; KATG315 GENE; LUNG TUBERCULOSIS; MOLECULAR DIAGNOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; POINT MUTATION; PROMOTER REGION; SEQUENCE ANALYSIS;

MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 84900554231     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-14-113     Document Type: Article

References (52)

1. Transmission of Mycobacterium tuberculosis from tuberculosis patients with HIV infection or AIDS. Cauthen GM, Dooley SW, Onorato IM, Ihle WW, Burr JM, Bigler WJ, Witte J, Castro KG, Am J Epidemiol 1996 144 1 69 77 (Pubitemid 26225289)
2. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G, Lancet 2006 368 9547 1575 1580 (Pubitemid 44780738)
3. WHO, Global Tuberculosis Control: WHO Report 2011 Geneva, Switzerland: WHO/HTM/TB/2011.16 2011
4. WHO, Global Tuberculosis Report 2012 Geneva Switzerland: WHO/HTM/TB/20126 2012
5. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Gillespie SH, Antimicrob Agents Chemother 2002 46 2 267 274 (Pubitemid 34087167)
6. Increasing drug resistance in extensively drug-resistant tuberculosis South Africa. Shah NS, Richardson J, Moodley P, Moodley S, Babaria P, Ramtahal M, Heysell SK, Li X, Moll AP, Friedland G, Sturm AW, Gandhi NR, Emerg Infect Dis 2011 17 3 510 513
7. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG, Nature 1998 393 6685 537 544 (Pubitemid 28319235)
8. Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens. Shamputa IC, Rigouts L, Portaels F, APMIS 2004 112 11-12 728 752
9. Rapid molecular detection of tuberculosis and rifampin resistance. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD, N Engl J Med 2010 363 11 1005 1015
10. Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approaches. Garcia De Viedma D, Clin Microbiol Infect 2003 9 5 349 359
11. Mechanisms of drug resistance in Mycobacterium tuberculosis. Zhang Y, Yew WW, Int J Tuberc Lung Dis 2009 13 11 1320 1330
12. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Sreevatsan S, Pan X, Stockbauer KE, Williams DL, Kreiswirth BN, Musser JM, Antimicrob Agents Chemother 1996 40 4 1024 1026 (Pubitemid 26115243)
13. Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. Okamoto S, Tamaru A, Nakajima C, Nishimura K, Tanaka Y, Tokuyama S, Suzuki Y, Ochi K, Mol Microbiol 2007 63 4 1096 1106 (Pubitemid 46188264)
14. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Plinke C, Rüsch-Gerdes S, Niemann S, Antimicrob Agents Chemother 2006 50 5 1900 1902
15. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Ramaswamy S, Musser JM, Tuber Lung Dis 1998 79 1 3 29 (Pubitemid 29050434)
16. embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation. Plinke C, Cox H, Zarkua N, Karimovich H, Braker K, Diel R, Rüsch-Gerdes S, Feuerriegel S, Niemann S, J Antimicrob Chemother 2010 65 1359 1367
17. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India. Jadaun GPS, Das R, Prashant U, Chauhan DS, Charma VD, Katoch VM, Int J Antimicrob Agents 2009 33 483 486
18. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, Cafrune PI, Espinoza RC, Palaci M, Telles MA, Ritacco V, Suffys PN, Lopes ML, Campelo CL, Miranda SS, Kremer K, da Silva PE, Fonseca Lde S, Ho JL, Kritski AL, Rossetti ML, BMC Microbiol 2009 9 39
19. African networks launch to boost clinical trial capacity. Dolgin E, Nat Med 2010 16 1 8
20. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA, Bull World Health Organ 1969 41 1 21 43
21. Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana. Homolka S, Meyer CG, Hillemann D, Owusu-Dabo E, Adjei O, Horstmann RD, Browne EN, Chinbuah A, Osei I, Gyapong J, Kubica T, Ruesch-Gerdes S, Niemann S, Int J Med Microbiol 2010 300 7 489 495
22. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Sreevatsan S, Stockbauer KE, Pan X, Kreiswirth BN, Moghazeh SL, Jacobs WR Jr, Telenti A, Musser JM, Antimicrob Agents Chemother 1997 41 8 1677 1681 (Pubitemid 27339866)
23. Emb nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutol. Srivastavaa S, Ayyagaria A, Dholea TN, Nyatia KK, Dwivedi SK, Int J Med Microbiol 2009 299 269 280
24. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis. Abbadi SH, Sameaa GA, Morlock G, Cooksey RC, Int J Infect Dis 2009 13 6 673 678
25. Tuberculosis diagnosis in resource-limited settings: clinical use of GeneXpert in the diagnosis of smear-negative PTB: a case report. Nakiyingi L, Nankabirwa H, Lamorde M, Afr Health Sci 2013 13 2 522 524
26. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. Afanas'ev MV, Ikryannikova LN, Il'ina EN, Sidorenko SV, Kuz'min AV, Larionova EE, Smirnova TG, Chernousova LN, Kamaev EY, Skorniakov SN, Kinsht VN, Cherednichenko AG, Govorun VM, J Antimicrob Chemother 2007 59 6 1057 1064 (Pubitemid 47073315)
27. Molecular detection of mutations associated with first and second-line drug resistance compared with conventional drug susceptibility testing in M. tuberculosis. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE, Antimicrob Agents Chemother 2011 55 5 2032 2041
28. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates. Soudani A, Hadjfredj S, Zribi M, Masmoudi A, Messaoud T, Tiouri H, Fendri C, J Clin Microbiol 2007 45 9 3095 3097 (Pubitemid 47417364)
29. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S, J Clin Microbiol 2005 43 8 3699 3703 (Pubitemid 41129648)
30. Evidence of drug resistance among the LAM-Cameroon family in Mycobacterium tuberculosis isolates from Yaoundé Cameroon. Penlap BV, Victor T, Warren R, Jordaan A, Tedom ES, Titanji V, Cam J Acad Sc 2010 9 1 11 15
31. Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. Taniguchi H, Aramaki H, Nikaido Y, Mizuguchi Y, Nakamura M, Koga T, Yoshida S, FEMS Microbiol Lett 1996 144 1 103 108 (Pubitemid 26343117)
32. rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy. Pozzi G, Meloni M, Iona E, Orru G, Thoresen OF, Ricci ML, Oggioni MR, Fattorini L, Orefici G, J Clin Microbiol 1999 37 4 1197 1199 (Pubitemid 29140640)
33. rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries. Qian L, Abe C, Lin TP, Yu MC, Cho SN, Wang S, Douglas JT, J Clin Microbiol 2002 40 3 1091 1094 (Pubitemid 34208678)
34. Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin. Zaczek A, Brzostek A, Augustynowicz-Kopec E, Zwolska Z, Dziadek J, BMC Microbiol 2009 9 10
35. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, Matter L, Schopfer K, Bodmer T, Lancet 1993 341 8846 647 650 (Pubitemid 23083244)
36. Characterization of rifampin-resistance in pathogenic mycobacteria. Williams DL, Waguespack C, Eisenach K, Crawford JT, Portaels F, Salfinger M, Nolan CM, Abe C, Sticht-Groh V, Gillis TP, Antimicrob Agents Chemother 1994 38 10 2380 2386
37. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Ohno H, Koga H, Kohno S, Tashiro T, Hara K, Antimicrob Agents Chemother 1996 40 4 1053 1056 (Pubitemid 26115251)
38. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. Mani C, Selvakumar N, Narayanan S, Narayanan PR, J Clin Microbiol 2001 39 8 2987 2990 (Pubitemid 32744028)
39. Drug Resistance in Mycobacterium tuberculosis. Johnson R, Streicher EM, Louw GE, Warren RM, van Helden PD, Victor TC, Curr Issues Mol Biol 2009 8 97 112 (Pubitemid 44121991)
40. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B, Antimicrob Agents Chemother 2002 46 5 1417 1424 (Pubitemid 34415323)
41. Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. Sajduda A, Brzostek A, Poplawska M, Augustynowicz-Kopec E, Zwolska Z, Niemann S, Dziadek J, Hillemann D, J Clin Microbiol 2004 42 6 2425 2431 (Pubitemid 38747484)
42. Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR. van Doorn HR, An DD, de Jong MD, Lan NT, Hoa DV, Quy HT, Chau NV, Duy PM, Tho DQ, Chinh NT, Farrar JJ, Caws M, Int J Tuberc Lung Dis 2008 12 7 736 742 (Pubitemid 351976702)
43. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Bakonyte D, Baranauskaite A, Cicenaite J, Sosnovskaja A, Stakenas P, Antimicrob Agents Chemother 2003 47 6 2009 2011 (Pubitemid 36637834)
44. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology. Tudo G, Gonzalez J, Obama R, Rodriguez JM, Franco JR, Espasa M, Simarro PR, Escaramis G, Ascaso C, Garcia A, Jimenez De Anta MT, Int J Tuberc Lung Dis 2004 8 1 15 22 (Pubitemid 38120701)
45. Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. Chaoui I, Sabouni R, Kourout M, Jordaan AM, Lahlou O, Elouad R, Akrim M, Victor TC, El Mzibri M, J Infect Dev Ctries 2009 3 4 278 284
46. Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea. Cho EH, Bae HK, Kang SK, Lee EH, Korean J Lab Med 2009 29 5 455 460
47. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Siddiqi N, Shamim M, Hussain S, Choudhary RK, Ahmed N, Prachee BS, Savithri GR, Alam M, Pathak N, Amin A, Hanief M, Katoch VM, Sharma SK, Hasnain SE, Antimicrob Agents Chemother 2002 46 2 443 450 (Pubitemid 34087194)
48. Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville Spain. Torres MJ, Criado A, Gonzalez N, Palomares JC, Aznar J, Int J Tuberc Lung Dis 2002 6 2 160 163 (Pubitemid 34263708)
49. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona. Tudo G, Rey E, Borrell S, Alcaide F, Codina G, Coll P, Martin-Casabona N, Montemayor M, Moure R, Orcau A, Salvado M, Vicente E, Gonzalez-Martin J, J Antimicrob Chemother 2010 65 11 2341 2346
50. Detection of resistance-associated mutations in Mycobacterium tuberculosis isolates in Cameroon using a dot-blot hybridisation technique. Mbacham FW, Tientcheu LD, Beng Penlap V, Kuaban C, Eyangoh S, Wang H, Bickii J, Netongo PM, Titi Lembe W, Olama A, Njikam N, Teyim P, Khan B, Afr J Biotechnol 2011 10 53 11016 11022
51. Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Silva PE, Bigi F, Santangelo MP, Romano MI, Martin C, Cataldi A, Ainsa JA, Antimicrob Agents Chemother 2001 45 3 800 804 (Pubitemid 32182029)
52. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles B, Musser JM, Jacobs WR Jr, Nat Med 1997 3 5 567 570 (Pubitemid 27198658) Partnership